People

Inhaled drug developer Senzer has announced major changes to its management "aimed at bolstering its commercialization strategy for COVID-19 and cannabinoid treatments." In May 2020, Senzer announced that it was developing two inhaled anti-virals delivered via MDI for the treatment of COVID-19 in addition to the cannabinoids it is developing based on its Systemic … [Read more...] about Senzer announces management changes, including new Chairman and CEO

Inhalation Sciences (ISAB) has named TFS Trial Form Support International Founder Daniel Spasic as Chairman of the Board. Spasic serves on the boards of several other companies, including connected spirometer maker NuvoAir. In May 2019, Inhalation Sciences announced that it intended to validate its PreciseInhale dosing system, which produces aerosols at a specified … [Read more...] about Inhalation Sciences appoints Daniel Spasic as Chairman of the Board

Inhaled drug CDMO Vectura has announced the appointments of Trevor Archbold, Robert Gurley, and Chris Vernall as Business Development Directors, reporting to recently appointed Chief Commercial Officer Mark Bridgewater. Archbold and Vernall will cover Europe; Gurley will be responsible for the US West Coast. Archbold was most recently Strategic Account Manager, … [Read more...] about Vectura appoints three new Business Development Directors

Liquidia Technologies has announced the appointment of former Teva Pharmaceuticals Global Head of Specialty Clinical Development Tushar Shah as the company's first Chief Medical Officer. Prior to his most recent position, Shah had served as Senior VP, Global Respiratory Research and Development at Teva. His career in pharmaceutical research has also included positions … [Read more...] about Tushar Shah joins Liquidia Technologies as Chief Medical Officer

Impel NeuroPharma has announced the resignation of Jon Congleton as President and CEO; Adrian Adams, who was appointed as Impel's Chairman of the Board of Directors in January 2020, will now add the CEO role. Adams has previously served as CEO of a number of pharmaceutical companies, including Aralez, Auxilium, Neurologix, Inspire Pharmaceuticals, Sepracor, and Kos. … [Read more...] about Impel NeuroPharma Chairman Adrian Adams takes over CEO role as Jon Congleton steps down

Hovione has announced the appointment of former Evonik executive Jean-Luc Herbeaux as the company's new Chief Operating Officer. Herbeaux was most recently Senior VP and General Manager of Evonik's Health Care Business Line. He will be based at Hovione's headquarters in Lisbon, Portugal. Over the past few years, Hovione has been expanding production capacity at … [Read more...] about Hovione names Jean-Luc Herbeaux as Chief Operating Officer

Digital RDD 2020 got underway on April 26 with the announcement of the winner of the Charles G. Thiel Award for Outstanding Research and Discovery in Respiratory Drug Delivery. In a recorded presentation accessible to registered delegates, committee member Peter Byron announced that this year's award goes to Jeffry Weers, Chief Technology Officer of Respira … [Read more...] about 2020 Charles G. Thiel Award goes to Jeff Weers

Less than two weeks after announcing the promotion of Mike Motion from Chief Commercial Officer to Chief Operating Officer, inhaler monitoring company Adherium has named Motion as its new CEO, replacing interim CEO Jeremy Curnock Cook. The company also announced that it has hired former Menarini Asia-Pacific CFO Anne Bell as Chief Financial Officer. In November … [Read more...] about More management changes for Adherium

Intranasal vaccine developer BlueWillow Biologics has announced the appointment of Chad Costley as Chief Medical Officer. Costley, an Atlanta-based primary care physician, has previously served on BlueWillow's board of directors. BlueWillow, formerly known as NanoBio, has a number of intranasal vaccines based on its NanoVax technology in preclinical or Phase 1 … [Read more...] about BlueWillow announces appointment of Chad Costley as Chief Medical Officer